开云官方网站_开云（中国）

U.S. FDA Formally Accepts Beihai Biotech's New Drug Application for Innovative Oncology Drug BH009 (BEIZRAY™)

2024-01-04
Beihai Biotech Founder Dr. Sun Invited to Keynote 'Wisdom in China' Summit at Renmin University Business School

2023-12-26
Beihai Biotech Successfully Concludes Series C Funding, Expediting BH009 Commercialization and Advancing Clinical Trials for Innovative Drug Candidates

2023-12-19
Beihai Biotech Listed Among "Top 100 High-Growth Enterprises in the Greater Bay Area 2023"

2023-11-09
Innovation Recognized Again: Beihai Biotech Honored with GHP “Most Innovative Clinical-Stage Biopharmaceutical Company 2023”

2023-08-01
Beihai Biotech Secures “Drug Manufacturing Certificate”

2023-06-15
Landmark Clinical Research Findings of Beihai Biotech's BH009 Unveiled at ASCO 2023

2023-06-12
Beihai Biotech Earns a Spot on the “China Future Healthcare Rankings 2023-Top 100 Biomedicine Companies”

2023-05-08

开云网页版 | 09818开元（中国）官方网站 | kaiyun开云（中国入口）·官方网站 | 华体官网网页版_华体(中国) | 华亿体育（中国）科技股份公司 | pg电子游戏十大平台（中国）有限公司 | 乐鱼官方网站 | 新利官方(中国)责任有限公司 | 火狐电竞(中国)官方网站 |